Human cytomegalovirus immediate-early gene expression is restricted by the nuclear domain 10 component Sp100

Journal of General Virology

Volumn 92, Issue 7, 2011, Pages 1532-1538

  Adler, Martina ^a   Tavalai, Nina ^a   Müller, Regina ^a   Stamminger, Thomas ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HDAXX PROTEIN; NUCLEAR DOMAIN 10; NUCLEAR PROTEIN; PROMYELOCYTIC LEUKEMIA PROTEIN; SP100 PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; CONTROLLED STUDY; EXPRESSION VECTOR; FIBROBLAST; GENE EXPRESSION; GENE REPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; IMMEDIATE EARLY GENE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; SUMOYLATION; VIRAL GENETICS; VIRUS REPLICATION;

ANTIGENS, NUCLEAR; AUTOANTIGENS; CELL LINE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; GENE EXPRESSION REGULATION, VIRAL; HUMANS; IMMEDIATE-EARLY PROTEINS; NUCLEAR PROTEINS; VIRUS REPLICATION;

HUMAN HERPESVIRUS 5;

EID: 79959290376     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.030981-0     Document Type: Article

References (28)

1. Andreoni, M., Faircloth, M., Vugler, L. & Britt, W. J. (1989). A rapid microneutralization assay for the measurement of neutralizing antibody reactive with human cytomegalovirus. J Virol Methods 23, 157-167.
2. Bieniasz, P. D. (2004). Intrinsic immunity: a front-line defense against viral attack. Nat Immunol 5, 1109-1115.
3. Cantrell, S. R. & Bresnahan, W. A. (2006). Human cytomegalovirus (HCMV) UL82 gene product (pp71) relieves hDaxx-mediated repression of HCMV replication. J Virol 80, 6188-6191.
4. Cuchet, D., Sykes, A., Nicolas, A., Orr, A., Murray, J., Sirma, H., Heeren, J., Bartelt, A. & Everett, R. D. (2011). PML isoforms I and II participate in PML-dependent restriction of HSV-1 replication. J Cell Sci 124, 280-291.
5. de la Hoz, R. E., Stephens, G. & Sherlock, C. (2002). Diagnosis and treatment approaches of CMV infections in adult patients. J Clin Virol 25 ((Suppl. 2),), S1-S12.
6. Dent, A. L., Yewdell, J., Puvion-Dutilleul, F., Koken, M. H., de The, H. & Staudt, L. M. (1996). LYSP100-associated nuclear domains (LANDs): description of a new class of subnuclear structures and their relationship to PML nuclear bodies. Blood 88, 1423-1426.
7. Everett, R. D. & Chelbi-Alix, M. K. (2007). PML and PML nuclear bodies: implications in antiviral defence. Biochimie 89, 819-830.
8. Everett, R. D., Rechter, S., Papior, P., Tavalai, N., Stamminger, T. & Orr, A. (2006). PML contributes to a cellular mechanism of repression of herpes simplex virus type 1 infection that is inactivated by ICP0. J Virol 80, 7995-8005.
9. Everett, R. D., Parada, C., Gripon, P., Sirma, H. & Orr, A. (2008). Replication of ICP0-null mutant herpes simplex virus type 1 is restricted by both PML and Sp100. J Virol 82, 2661-2672.
10. Guldner, H. H., Szostecki, C., Grötzinger, T. & Will, H. (1992). IFN enhance expression of Sp100, an autoantigen in primary biliary cirrhosis. J Immunol 149, 4067-4073.
11. Guldner, H. H., Szostecki, C., Schröder, P., Matschl, U., Jensen, K., Löders, C., Will, H. & Sternsdorf, T. (1999). Splice variants of the nuclear dot-associated Sp100 protein contain homologies to HMG-1 and a human nuclear phosphoprotein-box motif. J Cell Sci 112, 733-747.
12. Ishov, A. M., Sotnikov, A. G., Negorev, D., Vladimirova, O. V., Neff, N., Kamitani, T., Yeh, E. T., Strauss, J. F., III & Maul, G. G. (1999). PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1. J Cell Biol 147, 221-234.
13. Lavau, C., Marchio, A., Fagioli, M., Jansen, J., Falini, B., Lebon, P., Grosveld, F., Pandolfi, P. P., Pelicci, P. G. & Dejean, A. (1995). The acute promyelocytic leukaemia-associated PML gene is induced by interferon. Oncogene 11, 871-876.
14. Marschall, M., Freitag, M., Weiler, S., Sorg, G. & Stamminger, T. (2000). Recombinant green fluorescent protein-expressing human cytomegalovirus as a tool for screening antiviral agents. Antimicrob Agents Chemother 44, 1588-1597.
15. Negorev, D. G., Vladimirova, O. V. & Maul, G. G. (2009). Differential functions of interferon-upregulated Sp100 isoforms: herpes simplex virus type 1 promoter-based immediate-early gene suppression and PML protection from ICP0-mediated degradation. J Virol 83, 5168-5180.
16. Preston, C. M. & Nicholl, M. J. (2006). Role of the cellular protein hDaxx in human cytomegalovirus immediate-early gene expression. J Gen Virol 87, 1113-1121.
17. Saffert, R. T. & Kalejta, R. F. (2006). Inactivating a cellular intrinsic immune defense mediated by Daxx is the mechanism through which the human cytomegalovirus pp71 protein stimulates viral immediateearly gene expression. J Virol 80, 3863-3871.
18. Seeler, J. S., Marchio, A., Losson, R., Desterro, J. M., Hay, R. T., Chambon, P. & Dejean, A. (2001). Common properties of nuclear body protein SP100 and TIF1alpha chromatin factor: role of SUMO modification. Mol Cell Biol 21, 3314-3324.
19. Stadler, M., Chelbi-Alix, M. K., Koken, M. H., Venturini, L., Lee, C., Saïb, A., Quignon, F., Pelicano, L., Guillemin, M. C. & other authors (1995). Transcriptional induction of the PML growth suppressor gene by interferons is mediated through an ISRE and a GAS element. Oncogene 11, 2565-2573.
20. Stuurman, N., de Graaf, A., Floore, A., Josso, A., Humbel, B., de Jong, L. & van Driel, R. (1992). A monoclonal antibody recognizing nuclear matrix-associated nuclear bodies. J Cell Sci 101, 773-784.
21. Szostecki, C., Guldner, H. H., Netter, H. J. & Will, H. (1990). Isolation and characterization of cDNA encoding a human nuclear antigen predominantly recognized by autoantibodies from patients with primary biliary cirrhosis. J Immunol 145, 4338-4347.
22. Tavalai, N. & Stamminger, T. (2008). New insights into the role of the subnuclear structure ND10 for viral infection. Biochim Biophys Acta 1783, 2207-2221.
23. Tavalai, N. & Stamminger, T. (2010). Intrinsic cellular defense mechanisms targeting human cytomegalovirus. Virus Res (In Press).
24. Tavalai, N., Papior, P., Rechter, S., Leis, M. & Stamminger, T. (2006). Evidence for a role of the cellular ND10 protein PML in mediating intrinsic immunity against human cytomegalovirus infections. J Virol 80, 8006-8018.
25. Tavalai, N., Papior, P., Rechter, S. & Stamminger, T. (2008). Nuclear domain 10 components promyelocytic leukemia protein and hDaxx independently contribute to an intrinsic antiviral defense against human cytomegalovirus infection. J Virol 82, 126-137.
26. Van Damme, E., Laukens, K., Dang, T. H. & Van Ostade, X. (2010). A manually curated network of the PML nuclear body interactome reveals an important role for PML-NBs in SUMOylation dynamics. Int J Biol Sci 6, 51-67.
27. Woodhall, D. L., Groves, I. J., Reeves, M. B., Wilkinson, G. & Sinclair, J. H. (2006). Human Daxx-mediated repression of human cytomegalovirus gene expression correlates with a repressive chromatin structure around the major immediate early promoter. J Biol Chem 281, 37652-37660.
28. Zhong, S., Müller, S., Ronchetti, S., Freemont, P. S., Dejean, A. & Pandolfi, P. P. (2000). Role of SUMO-1-modified PML in nuclear body formation. Blood 95, 2748-2752.